NASDAQ:AXSM

Axsome Therapeutics Stock News

etoro logo Buy AXSM
*Your capital is at risk
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Some traders appear to be taking profits off the table after the stock's jump last week.
The drugmaker received good news from the FDA for one of its pipeline candidates.
Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Admin
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) Brainstorm Cell...
Two Sigma Advisers LP increased its stake in Axsome Therapeutics Inc (NASDAQ:AXSM) by 342.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 118,100
Axsome is planning to submit NDAs later this year for its 2 leading indications. These 2 indications alone have projected peak sales up to $3 billion, but Axsom
Alliancebernstein L.P. grew its position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 11.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Comm
AlphaCrest Capital Management LLC purchased a new position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 3,800 s
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Sowell Financial Services LLC cut its holdings in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 48.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 844
State Street Corp increased its stake in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 5.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 661,315 shares
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rockefeller Capital Management L.P. bought a new position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) during the 1st quarter, according to its most recent disclosure with the SEC. The fund boug
Q1 2020 Axsome Therapeutics Inc Earnings Call
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE